CYSTIC FIBROSIS PROGRAM RELATED INVESTMENT AGREEMENT by and between Corbus Pharmaceuticals, Inc. and Cystic Fibrosis Foundation Cystic Fibrosis Program Related Investment AgreementCystic Fibrosis Program Related Investment Agreement • March 12th, 2018 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Maryland
This Agreement (this “Agreement”) is made on this 26th day of January, 2018 (the “Effective Date”) by and between Corbus Pharmaceuticals, Inc. (“Corbus”), a Delaware corporation, with its principal office at 100 River Ridge Drive, Norwood, MA 02062, and Cystic Fibrosis Foundation (“CFF”), a nonprofit corporation with its principal offices at 4550 Montgomery Ave, Bethesda, Maryland, 20814. Corbus and CFF are each a “Party,” and, collectively, the “Parties.”
